查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853709

血栓除去装置市场（按器械类型、手术类型、最终用户和分销管道划分）—2025-2032年全球预测

Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，血栓除去装置市场规模将达到 23.4182 亿美元，复合年增长率为 13.09%。

关键市场统计数据
基准年2024年 8.75亿美元
预计年份：2025年 9.9209亿美元
预测年份 2032 23.4182亿美元
复合年增长率 (%) 13.09%

建立临床、营运和采购基础，以影响现代急性中风护理环境中神经血栓切除装置的选择。

神经血栓切除装置已成为急性中风治疗路径中的关键环节，这主要得益于临床的快速应用、手术技术的创新以及医疗环境的不断演变。本文概述了影响装置设计、采购决策和应用曲线的关键技术、临床驱动因素以及相关人员事项。透过将各种装置置于目前的手术方案中，本文阐明了技术属性如何转化为实际的临床应用效用和操作偏好。

临床医生和医疗系统领导者如今面临这样的局面：器械的选择与影像处理能力、再灌注时间以及医疗机构的容量息息相关。因此，製造商优先考虑的是易用性、与现有导管室工作流程的兼容性以及在不同血管解剖结构中一致的临床性能。同时，支付方和采购团队更重视总医疗成本和后续疗效，进而推动临床证据与采购策略的更紧密结合。

在此背景下，引言部分提供了一个视角，用于审视技术变革、关税影响、细分市场动态、区域格局以及公司层面的策略。本文旨在帮助相关人员结合自身的营运和临床优先事项来解读这些洞察，并将其转化为产品开发、市场推广和供应链优化的可行计划。

梳理正在重塑急性中风治疗设备设计、应用偏好和策略重点的技术、临床和系统层面的融合力量。

神经血栓切除术领域正经历一场变革，技术、​​临床和系统层面的多重因素共同推动急性缺血性脑中风的治疗方式重塑。影像技术的进步和从入院到再灌注流程的简化，使得器械的输送性和可追踪性变得愈发重要，促使设计不断迭代，优先考虑更细的入路、更精准的导航和更强的抽吸能力。同时，临床证据也不断完善抽吸优先和联合治疗两种策略的选择标准，鼓励器材製造商投资研发多功能、整合的解决方案。

专科中风中心的扩张、多学科中风团队的日益重视以及适宜的门诊手术中心的兴起，正在影响着医疗器械的配置和服务内容。监管路径和上市后监测提高了绩效声明的严格性，製造商也透过建立更明确的临床註册和真实世界证据计画来应对这项挑战。同时，从手术规划软体到人工智慧影像分诊等数位化技术的应用，为医疗器材融入更广泛的医疗生态系统而非仅仅作为独立产品提供了契机。

总而言之，这些转变将加速创新週期，提高临床检验的标准，并对现有企业和新参与企业施加策略压力，促使它们在疗效、易用性和整体流程效率方面展现差异化价值。因此，成功的公司将能够使其产品开发与不断发展的医疗保健路径和相关人员的期望保持一致。

分析累积关税环境和2025年贸易政策调整如何重塑相关人员的供应链韧性、筹资策略和定价动态。

近期贸易政策的发展以及2025年生效的关税调整，为神经血栓切除术器械的全球供应链引入了新的变数。这些变化带来的累积影响远不止于直接的成本上涨，还会波及製造地的选择、关键零件的筹资策略以及跨境分销的经济效益。为此，许多製造商正在重新评估其供应商关係，探索近岸外包、双重采购以及增加库存缓衝等策略，以缓解关税带来的波动。这些变更将对采购时间表以及与医院和经销商的合约条款产生后续影响。

医院和专科中心面临更复杂的采购计算，不仅要考虑设备定价，还要考虑服务连续性和前置作业时间风险。特别是那些依赖单一供应商和即时库存模式的机构，不得不重新谈判条款或采取紧急库存策略。面对利润净利率的萎缩，经销商正在透过提供配套服务、寄售模式以及区域化的消毒和物流解决方案来重新定义其价值提案，以应对不断上涨的关税相关成本并保持竞争力。

监管和报销条件与关税效应相互作用，共同影响医疗器械的普及时间。不断上涨的采购成本使得支付方更加关注成本效益和长期疗效，从而加强了对医疗器械优越性声明的审查力度。因此，製造商必须提供可靠的临床和经济证据，以证明其定价在采购谈判中的合理性。总而言之，2025年的关税环境正在推动製造、分销和采购等各相关人员进行策略调整，凸显了供应链韧性和实证定价策略的重要性。

深入剖析决定神经血栓切除解决方案临床适用性、采购偏好和商业性定位的设备、手术、最终用户和分销管道细分方面的细微差别。

细分市场层面的动态变化揭示了因器械类型、手术方法、最终用户环境和通路而异的细微机会和限制。在器械类型细分市场中，抽吸导管可根据内径进一步区分。中等直径导管优先考虑灵活性和在迂曲解剖结构中的导航性，而大直径设计则优先考虑抽吸能力，以便快速清除血栓。组合系统涵盖了从将抽吸和取出功能整合到单一工作流程中的完全整合系统，到能够将一流组件组合起来以应对复杂病例的独立辅助解决方案。血栓摘取支架呈现涂层和非涂层设计的独特细分，其中表面处理会影响血栓与器械的相互作用和输送特性。

按手术类型进行分类反映了不同的临床工作流程和预期器械性能。抽吸血栓切除术通常用于可透过抽吸快速实现管腔再通的病例，而当需要径向力和基于支架的介入时，则首选使用取栓器的机械血栓切除术。两种方法可以按顺序进行，先尝试抽吸，然后根据需要部署取栓器；或者可以协调地同时使用互补器械，以最大限度地提高首次通过率并最大限度地缩短手术时间。

门诊手术中心需要精简高效的系统，并儘可能减少辅助设备；而设有综合卒中中心和初级卒中中心的医院则需要能够与各种导管室配置兼容，并能应对各种复杂病例的设备。专科神经病学中心则期望获得可靠的临床证据和训练支持，以优化治疗效果。直销模式强调厂商与临床医生之间的合作关係，电子商务支援标准耗材的快速补充，而第三方分销商（包括独立分销商和增值分销商）则在提供物流和临床培训服务的同时，拓展了业务覆盖范围。

检验了美洲、欧洲、中东和非洲以及亚太地区医疗设备相关人员在临床、监管和商业性存在的区域差异所带来的影响。

区域格局正在影响美洲、欧洲、中东和非洲以及亚太地区的临床实践、监管预期和商业策略，给市场参与企业带来了不同的挑战。在美洲，对成熟的中风网路和综合中风中心的投资推动了先进取栓设备的快速普及，而更广泛的地域差异则持续催生了对能够促进远端分流和传输通讯协定的解决方案的需求。因此，供应商通常会优先考虑全面的服务模式、完善的培训计划以及与不同医疗保健系统相关的实证实践。

欧洲、中东和非洲各地监管协调、报销差异以及卒中治疗基础设施的不同，既带来了机会，也带来了挑战。跨国监管路径鼓励采用模组化产品策略和区域性临床实务。以结果为导向的支付模式奖励商提供区域性真实世界证据。同时，亚太地区的医疗保健系统高度重视成本控制和价值验证，影响了采购週期和竞标结构。

亚太地区医疗保健成熟度有差异，主要市场大力投资中风治疗，而新兴市场则优先考虑可扩展、经济高效的解决方案。基础设施的快速扩张和专家能力的提升，推动了对兼具临床疗效和可靠供应的医疗器材的需求。在整个亚太地区，策略性参与企业正根据当地的健保报销机制、培训要求和物流实际情况调整其商业性策略，以最大限度地提高市场相关性和普及率。

从全球领导企业到专业创新者和契约製造，评估不同的企业策略如何影响产品蓝图和竞争优势。

公司层面的动态反映了一系列策略姿态，涵盖了从大型全球医疗技术公司到敏捷的专业研发和契约製造。成熟的跨国公司通常利用广泛的临床试验项目、广泛的分销网络和一体化的服务来维持其市场地位，而挑战者则专注于细分市场差异化，例如提高药物输送效率、独特的恢復机製或针对特定解剖结构或血栓成分挑战的联合治疗。为了应对竞争压力，合作和有针对性的协作正变得越来越普遍，以此来加快产品上市速度并扩大临床检验范围。

製造商们也正在重新分配研发投资，致力于开发能够缩短手术时间和提高首次疗效的功能。同时，规模较小的创新企业则优先考虑能够快速进入特定地域市场的监管策略，并规划在初步临床应用后扩大规模。製造外包和策略采购合作伙伴在扩大产能和降低关税风险方面发挥着至关重要的作用，这促使许多公司製定正式的供应链风险管理通讯协定。

此外，透过培训、流程支援和数据主导的市场研究实现服务差异化正成为一项关键的竞争优势。能够有效结合产品创新、便利的临床教育和长期疗效追踪的公司，将更有利于影响医院的处方笺，并长期赢得临床医生的青睐。

一项切实可行的多方相关人员策略，旨在协调产品创新、供应链韧性和循证采购，以实现持续的临床应用和竞争优势。

产业领导者应采取多维策略，将产品创新与供应链韧性和相关人员为中心的商业模式结合。製造商应优先发展模组化设备组合，使临床医生能够根据手术复杂程度选择合适的设备，同时保持生产规模经济效益。此外，供应商多元化以及探索区域组装或製造中心可以降低关税主导的衝击，并提高对区域采购週期的应对力。

临床医师和医院采购团队应加强以临床医师主导的评估框架，强调实际绩效指标、训练支援和整体流程效率，而非仅仅关注单位成本。这种方法有助于做出更明智的采购决策，并更好地与以结果为导向的报销模式相契合。经销商和通路合作伙伴必须透过提供物流优化、寄售模式和完善的临床培训服务来提升自身提案，从而支援不同医疗机构的设备应用和维护。

最后，政策制定者和支付者应考虑建立奖励机制，鼓励循证医学证据的产生，支持公平获取先进的卒中治疗方案，并促进公私合作以加强医疗服务网络。透过实施涵盖研发、分销和临床应用的协调策略，相关人员可以在维持商业性可行性的同时，加速显着改善病患预后。

采用多层次的研究途径，整合临床专家访谈、监管和程序文献以及供应链分析，确保获得有效且可操作的见解。

本调查方法采用多层次方法，整合定性和定量数据，旨在平衡临床相关性和实际操作性。主要研究包括对介入性神经放射科医生、神经外科医生、中风计画主任、医院采购负责人和分销主管进行结构化访谈，以了解手术偏好、采购标准和供应链限制。次要研究涵盖同行评审的临床研究、监管文件、器械标籤和公开的手术指南，以支持临床疗效声明和实践模式。

分析人员交叉参考了设备註册资讯、会议记录和製造商技术文檔，以识别设备迭代、手术结果和培训实践中的常见趋势。供应链分析包括供应商映射、组件采购审查和物流评估，以发现关税敏感性和前置作业时间漏洞。在适当情况下，透过后续专家咨询检验研究结果，以确保结论反映当前的临床实践和营运实际情况。

市场调查固有的限制已被认识并加以缓解。独家定价安排和保密采购合约限制了对具体商业条款的了解，而快速发展的临床证据可能会改变临床实践模式。为了克服这些局限性，我们提出了一些建议，强调调查方法和资料来源的透明度，在资料不完整时采取保守的推断，并优先考虑适应性和持续的证据收集。

对结论的全面回顾强调了神经血栓切除术的长期成功将取决于临床表现、营运韧性和实证商业化。

我们的结论概括了技术创新、流程改善和近期贸易动态如何共同影响神经血栓切除术生态系统的策略决策。在重视快速再灌注和简化工作流程的医疗领域，那些在首次通过率、操作便利性和跨平台相容性方面具有显着优势的器材将保持竞争力。同时，关税带来的供应链压力凸显了製造弹性、采购多元化和增值分销模式在维持服务连续性方面的重要性。

儘管区域性因素和最终用户需求需要量身定製商业策略，但可靠的临床证据和上市后绩效追踪在采购考量中仍然至关重要。注重产品差异化、并提供全面的临床医生培训和结果透明化的公司最有可能赢得持续的市场认可。同时，将采购决策与长期结果指标挂钩的医院和医疗系统，即使面临短期成本压力，也能更好地证明其对先进医疗设备投资的合理性。

最后，随着神经血栓切除术领域的不断成熟，相关人员积极将临床、营运和商业性方面整合到连贯策略中的利益相关者，将更有可能改善患者的治疗效果并获得可持续的竞争优势。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 采用优化径向力的先进血栓摘取支架设计，可提高缺血性中风介入治疗中血栓捕获效率。
  • 一种小型远端通路导管，能够引导医师穿过复杂迂曲的脑血管系统，进行标靶血栓切除术。
  • 它整合了即时人工智慧影像分析，以指导设备选择和手术流程。
  • 为了缩短手术时间并提高首次手术成功率，结合抽吸和支架取出的技术已经出现。
  • 采用机器人辅助神经血管介入平台可提高手术精度并减少外科医生受到的辐射暴露。
  • 开发一种可生物吸收的血栓除去装置，以最大程度地减少血管损伤和长期异物併发症。
  • 不断变化的报销政策和基于价值的医疗模式对医院采用血栓切除技术的影响
  • 中风发病率上升和血管内治疗基础设施不断扩大，推动了亚太市场的投资。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8.血栓除去装置市场（依器械类型划分）

  • 吸痰导管
    • 中口径
    • 大直径
  • 复杂系统
    • 整合系统
    • 独立辅助
  • 支架取栓器
    • 涂层
    • 未涂层

9. 依手术类型血栓除去装置市场

  • 抽吸血栓切除手术
  • 综合方法
    • 一连串
    • 同时
  • 机械血栓切除术

第十章 依最终用户分類的血栓除去装置市场

  • 门诊手术中心
  • 医院
    • 综合卒中中心
    • 初级卒中中心
  • 专科神经学中心

第十一章血栓除去装置市场（依通路划分）

  • 直销
  • 电子商务
  • 第三方经销商
    • 独立销售代理
    • 增值分销商

第十二章血栓除去装置市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章血栓除去装置市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国血栓除去装置市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Stryker Corporation
    • Medtronic plc
    • Penumbra, Inc.
    • Johnson & Johnson
    • Boston Scientific Corporation
    • Terumo Corporation
    • Imperative Care, Inc.
    • Rapid Medical Ltd.
    • Acandis GmbH & Co. KG
    • Phenox GmbH
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market is projected to grow by USD 2,341.82 million at a CAGR of 13.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 875.00 million
Estimated Year [2025] USD 992.09 million
Forecast Year [2032] USD 2,341.82 million
CAGR (%) 13.09%

Establishing the clinical, operational, and procurement foundations that shape neurothrombectomy device choices across contemporary acute stroke care settings

Neurothrombectomy devices have become a pivotal focal point across acute stroke care pathways, driven by rapid clinical adoption, procedural innovations, and evolving care settings. This introduction frames the essential technologies, clinical drivers, and stakeholder priorities that shape device design, procurement decisions, and adoption curves. By situating device types within contemporary procedural choices, the narrative clarifies how technical characteristics translate into real-world clinical utility and operational preferences.

Clinicians and health system leaders now confront a landscape where device selection intersects with imaging capabilities, time-to-reperfusion imperatives, and institutional capabilities. As a result, manufacturers are prioritizing ease of use, compatibility with existing cath lab workflows, and consistent clinical performance across variable vascular anatomies. Concurrently, payers and procurement teams emphasize total cost of care and downstream outcomes, prompting a closer alignment between clinical evidence and purchasing strategies.

In this context, the introduction establishes the lens through which subsequent sections examine technological shifts, tariff influences, segmentation-specific dynamics, regional patterns, and company-level strategies. It prepares stakeholders to interpret insights through operational and clinical priorities, and to translate them into actionable plans for product development, market access, and supply chain resilience.

Mapping the converging technological, clinical and system-level forces that are reshaping device design, adoption preferences, and strategic priorities in acute stroke care

The neurothrombectomy landscape is undergoing transformative shifts driven by converging technological, clinical and system-level forces that are redefining how acute ischemic stroke is treated. Imaging advances and faster door-to-reperfusion workflows have elevated the importance of device deliverability and trackability, prompting design iterations that prioritize lower-profile access, improved navigation, and enhanced aspiration performance. At the same time, clinical evidence continues to refine selection criteria for aspiration-first versus combined approaches, encouraging device makers to invest in versatility and integrated solutions.

Operational trends are also reshaping adoption: the expansion of specialized stroke centers, greater emphasis on multidisciplinary stroke teams, and the growth of ambulatory surgical centers where appropriate are influencing device configuration and service offerings. Regulatory pathways and post-market surveillance are adding rigor to performance claims, and manufacturers are responding with clearer clinical registries and real-world evidence programs. Meanwhile, digital augmentation-ranging from procedural planning software to AI-enabled imaging triage-creates opportunities for devices to be positioned as part of broader therapeutic ecosystems rather than stand-alone products.

Collectively, these shifts are accelerating innovation cycles, raising the bar for clinical validation, and creating strategic pressure on incumbents and new entrants to demonstrate differentiated value across efficacy, ease of use, and total procedural efficiency. As a result, successful players are those that align product development with evolving care pathways and stakeholder expectations.

Analyzing how the cumulative tariff environment and trade policy adjustments in 2025 are reshaping supply chain resilience, procurement strategies, and pricing dynamics across stakeholders

Recent trade policy developments and tariff adjustments implemented in 2025 have introduced new variables into global supply chains for neurothrombectomy devices. The cumulative effects extend beyond immediate cost uplifts, influencing manufacturing footprint decisions, sourcing strategies for critical components, and the economics of cross-border distribution. In response, many manufacturers are reassessing supplier relationships and exploring nearshoring, dual sourcing, and increased inventory buffers to mitigate tariff-driven volatility. These shifts have downstream implications for procurement timelines and contractual terms with hospitals and distributors.

Hospitals and specialized centers confront a more complex procurement calculus where device pricing must be considered alongside service continuity and lead-time risks. In particular, institutions that rely on single-source distributors or just-in-time inventory models have had to renegotiate terms or adopt contingency stock strategies. Distributors facing margin compression are redefining their value proposition by offering bundled services, consignment models, or localized sterilization and logistics solutions to preserve competitiveness while absorbing incremental tariff-related costs.

Regulatory and reimbursement landscapes interact with tariff effects to shape adoption timing. Payers emphasize cost-effectiveness and long-term outcomes, thereby increasing scrutiny on claims of device superiority when acquisition costs rise. Consequently, manufacturers must present robust clinical and economic evidence to justify pricing during procurement negotiations. In sum, the tariff environment of 2025 has catalyzed strategic repositioning across manufacturing, distribution, and purchasing stakeholders, reinforcing the need for supply chain resilience and evidence-based pricing strategies.

Unpacking device, procedural, end-user and distribution segmentation nuances that determine clinical fit, procurement preferences, and commercial positioning across neurothrombectomy solutions

Segment-level dynamics reveal nuanced opportunities and constraints that vary by device type, procedural approach, end-user setting and distribution pathway. Within device type segmentation, aspiration catheters are further differentiated by bore size, with intermediate bore variants emphasizing flexibility and navigation in tortuous anatomy while large bore designs prioritize aspiration capacity for rapid clot removal. Combined systems occupy a spectrum from fully integrated platforms that pair aspiration and retrieval functions in a single workflow to standalone adjunct solutions that allow clinicians to combine best-in-class components during complex cases. Stent retrievers present their own segmentation between coated and uncoated designs, where surface treatments can influence clot-device interactions and deliverability profiles.

Procedure type segmentation reflects distinct clinical workflows and device performance expectations. Aspiration thrombectomy is often selected for cases where fast lumen recanalization via suction is feasible, whereas mechanical thrombectomy with retrievers is preferred when radial force and scaffold-based engagement are required. The combined approach can be executed sequentially-attempting aspiration first and then deploying a retriever if needed-or simultaneously, with complementary devices used in concert to maximize first-pass effect and minimize procedural time.

End-user segmentation also matters: ambulatory surgical centers demand streamlined, efficient systems with minimal ancillary equipment, whereas hospitals, including both comprehensive and primary stroke centers, require devices that integrate with diverse cath lab setups and support variable case complexity. Specialized neurology centers expect robust clinical evidence and training support to optimize outcomes. Distribution channel segmentation influences how products reach the point of care; direct sales models emphasize manufacturer-clinician relationships, e-commerce supports rapid replenishment for standard disposables, and third-party distributors-both independent and value-added-extend geographic reach while providing logistical and clinical training services.

Examining how regional differences across the Americas, Europe Middle East & Africa, and Asia-Pacific create distinct clinical, regulatory and commercial imperatives for device stakeholders

Regional patterns shape clinical practice, regulatory expectations, and commercial strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific, yielding distinct imperatives for market participants. In the Americas, established stroke networks and investment in comprehensive stroke centers have fostered rapid adoption of advanced thrombectomy devices, while broader geographic disparities continue to create demand for solutions that facilitate remote triage and transfer protocols. Consequently, suppliers often prioritize comprehensive service models, robust training programs, and evidence generation relevant to diverse health systems.

In Europe, Middle East & Africa, regulatory harmonization, reimbursement variation, and differing stroke care infrastructures create both opportunities and complexities. Multi-country regulatory pathways encourage modular product strategies and region-specific clinical engagement. Payment models that reward outcome-based care have incentivized manufacturers to generate localized real-world evidence. In parallel, healthcare systems across the region emphasize cost containment and value demonstration, which affects procurement timelines and tender structures.

Asia-Pacific exhibits heterogeneity in healthcare maturity, with leading markets investing heavily in stroke capabilities and emerging markets emphasizing scalable, cost-effective solutions. Rapid infrastructure expansion and growing specialist capacity are increasing demand for devices that combine clinical efficacy with supply reliability. Across all regions, strategic entrants tailor commercial approaches to local reimbursement mechanisms, training requirements, and logistical realities to maximize market relevance and adoption.

Evaluating how diverse company strategies, from global incumbents to specialized innovators and contract manufacturers, are shaping product roadmaps and competitive differentiation

Company-level dynamics reflect a spectrum of strategic postures ranging from large global medtech firms to nimble specialized developers and contract manufacturers. Established multinational players often leverage broad clinical trial programs, extensive distribution networks, and integrated service offerings to maintain position, while challengers focus on niche differentiation through improved deliverability, unique retrieval mechanisms, or combination therapies that target specific anatomical or clot composition challenges. In response to competitive pressure, alliances and targeted collaborations have grown more common as a way to accelerate time-to-market and expand clinical validation efforts.

Manufacturers are also reallocating R&D investment toward features that reduce procedure time and improve first-pass effect, since these outcomes resonate with clinicians and payers alike. At the same time, smaller innovators increasingly prioritize regulatory strategies that enable rapid entry in select regional markets with the intent to scale after initial clinical adoption. Contract manufacturing and strategic sourcing partners play a critical role in enabling capacity expansion and mitigating tariff exposure, prompting many companies to formalize supply chain risk management protocols.

Furthermore, service differentiation through training, procedural support, and data-driven post-market surveillance has emerged as a key competitive lever. Companies that effectively combine product innovation with accessible clinical education and longitudinal outcome tracking are better positioned to influence hospital formularies and gain clinician preference over time.

Practical, multi-stakeholder strategies to align product innovation, supply chain resilience and evidence-driven procurement for sustained clinical adoption and competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with supply chain robustness and stakeholder-centric commercial models. Manufacturers need to prioritize modular device portfolios that allow clinicians to tailor device selection to procedural complexity while maintaining economies of scale in production. Concurrently, diversifying supplier bases and exploring regional assembly or manufacturing hubs will reduce exposure to tariff-driven disruptions and improve responsiveness to local procurement cycles.

Clinicians and hospital procurement teams should strengthen clinician-led evaluation frameworks that emphasize real-world performance metrics, training support, and total procedural efficiency rather than focusing solely on unit price. This approach will facilitate informed purchasing decisions and enable better alignment with outcome-oriented reimbursement models. Distributors and channel partners must enhance their value proposition by offering logistics optimization, consignment models, and robust clinical training services that support device adoption and retention within varied care settings.

Finally, policymakers and payers should consider mechanisms that incentivize evidence generation, support equitable access to advanced stroke interventions, and encourage public-private collaboration to strengthen care networks. By implementing coordinated strategies across development, distribution, and clinical adoption, stakeholders can accelerate meaningful improvements in patient outcomes while sustaining commercial viability.

A layered research approach integrating clinical expert interviews, regulatory and procedural literature, and supply chain analysis to ensure validated and actionable insights

This research synthesizes qualitative and quantitative inputs using a layered methodology designed to balance clinical validity with operational realism. Primary research included structured interviews with interventional neuroradiologists, neurosurgeons, stroke program directors, hospital procurement officers, and distribution executives to capture procedural preferences, purchasing criteria, and supply chain constraints. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, device labeling, and publicly available procedural guidelines to corroborate clinical performance claims and practice patterns.

Analysts triangulated insights with device registries, conference proceedings, and manufacturer technical documentation to identify recurring trends in device iteration, procedural outcomes, and training practices. Supply chain analysis incorporated vendor mapping, component sourcing reviews, and logistics assessments to highlight tariff sensitivities and lead-time vulnerabilities. Where appropriate, findings were validated through follow-up expert consultations to ensure conclusions reflect current clinical practice and operational realities.

Limitations inherent to market research were acknowledged and mitigated: proprietary pricing arrangements and confidential procurement contracts constrain visibility into certain commercial terms, and rapidly evolving clinical evidence can shift practice patterns. To address these limitations, the methodology emphasizes transparent sourcing, conservative inference where data are incomplete, and recommendations that prioritize adaptability and ongoing evidence collection.

Concluding synthesis highlighting how clinical performance, operational resilience, and evidence-based commercialization determine long-term success in neurothrombectomy

The conclusion distills how technological innovation, procedural evolution, and recent trade dynamics collectively influence strategic decision-making across the neurothrombectomy ecosystem. Devices that deliver demonstrable improvements in first-pass effect, ease of navigation, and cross-platform compatibility will retain a competitive edge as care pathways emphasize rapid reperfusion and streamlined workflows. At the same time, tariff-induced supply chain pressures have underscored the importance of manufacturing agility, diversified sourcing, and value-added distribution models in maintaining service continuity.

Region-specific considerations and end-user priorities demand tailored commercial strategies, while robust clinical evidence and post-market performance tracking remain decisive in procurement deliberations. Companies that combine focused product differentiation with comprehensive clinician training and outcome transparency are most likely to win sustained adoption. Meanwhile, hospitals and health systems that align purchasing decisions with long-term outcome metrics can better justify investments in advanced devices despite short-term cost pressures.

In closing, stakeholders that proactively integrate clinical, operational, and commercial dimensions into cohesive strategies will be best positioned to deliver improved patient outcomes and realize durable competitive advantage as the neurothrombectomy field continues to mature.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advanced stent retriever designs with optimized radial force for improved clot capture efficiency in ischemic stroke interventions
  • 5.2. Miniaturized distal access catheters enabling navigation in challenging tortuous cerebral vasculature for targeted thrombectomy
  • 5.3. Integration of real time artificial intelligence driven imaging analytics to guide device selection and procedural workflow
  • 5.4. Emergence of combined aspiration plus stent retrieval techniques to reduce procedure times and enhance first pass efficacy
  • 5.5. Adoption of robotics assisted neuroendovascular platforms to improve procedural precision and reduce operator radiation exposure
  • 5.6. Development of bioresorbable neurothrombectomy devices to minimize vessel trauma and long term foreign body complications
  • 5.7. Impact of evolving reimbursement policies and value based care models on hospital adoption of thrombectomy technologies
  • 5.8. Growing investment in Asia Pacific markets driven by rising stroke incidence and expansion of endovascular care infrastructure

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurothrombectomy Devices Market, by Device Type

  • 8.1. Aspiration Catheters
    • 8.1.1. Intermediate Bore
    • 8.1.2. Large Bore
  • 8.2. Combined Systems
    • 8.2.1. Integrated System
    • 8.2.2. Standalone Adjunct
  • 8.3. Stent Retrievers
    • 8.3.1. Coated
    • 8.3.2. Uncoated

9. Neurothrombectomy Devices Market, by Procedure Type

  • 9.1. Aspiration Thrombectomy
  • 9.2. Combined Approach
    • 9.2.1. Sequential
    • 9.2.2. Simultaneous
  • 9.3. Mechanical Thrombectomy

10. Neurothrombectomy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Comprehensive Stroke Centers
    • 10.2.2. Primary Stroke Centers
  • 10.3. Specialized Neurology Centers

11. Neurothrombectomy Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. E Commerce
  • 11.3. Third Party Distributor
    • 11.3.1. Independent Distributor
    • 11.3.2. Value Added Distributor

12. Neurothrombectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurothrombectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurothrombectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Stryker Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Penumbra, Inc.
    • 15.3.4. Johnson & Johnson
    • 15.3.5. Boston Scientific Corporation
    • 15.3.6. Terumo Corporation
    • 15.3.7. Imperative Care, Inc.
    • 15.3.8. Rapid Medical Ltd.
    • 15.3.9. Acandis GmbH & Co. KG
    • 15.3.10. Phenox GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2025-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 298. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MI